Advertisement
Screener

ELI LILLY AND COMPANY (LLY) Return on Tangible Equity

2.8 / 5 stars · 68/120 Roast Me

ELI LILLY & Co Return Tang Equity

Return on tangible equity is the profit a company earns on the physical and financial capital its shareholders own, leaving out goodwill and other intangible assets, shown as a percentage. It is net income divided by tangible equity, which is shareholder equity minus goodwill and intangibles; the table shows both amounts. Because acquired goodwill is removed, it runs higher than ROE for companies that grew by acquisition, and it has no meaning when goodwill exceeds equity. Goodwill and intangibles are taken at the latest reported date on or before each equity date. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • ELI LILLY & Co return tang equity for the quarter ending 2025-09-30 was 145.92%, a 43.90% decline year-over-year.
  • ELI LILLY & Co return tang equity for the quarter ending 2025-06-30 was 190.51%, a 34.29% decline year-over-year.
  • ELI LILLY & Co return tang equity for the quarter ending 2025-03-31 was 234.23%, a 0.10% increase year-over-year.
  • ELI LILLY & Co return tang equity for the quarter ending 2024-12-31 was 334.41%, a 62.40% decline year-over-year.
  • ELI LILLY & Co return tang equity for fiscal 2024 was 334.41%, a 62.40% decline from fiscal 2023.
  • ELI LILLY & Co return tang equity for fiscal 2023 was 889.34%, a 94.76% increase from fiscal 2022.
  • ELI LILLY & Co return tang equity for fiscal 2022 was 456.62%, a change of 1563.89% from fiscal 2021.
  • ELI LILLY & Co return tang equity for fiscal 2021 was -1107.26%, a change of -962.90% from fiscal 2020.
Available history
2008-12-31 to 2025-09-30
Data captured

Historical Return Tang Equity

DateReturn Tang EquityNet income 12 monthTangible equity
2025-09-30145.92%$18.41B$12.62B
2025-06-30190.51%$13.8B$7.24B
2025-03-31234.23%$11.11B$4.74B
2024-12-31334.41%$10.59B$3.17B
2024-09-30260.12%$8.37B$3.22B
2024-06-30289.90%$7.34B$2.53B
2024-03-31234.01%$6.14B$2.62B
2023-12-31889.34%$5.24B$589.2M
2023-09-30264.30%$4.99B$1.89B
2023-06-30374.37%$6.5B$1.74B
2023-03-31301.37%$5.69B$1.89B
2022-12-31456.62%$6.24B$1.37B
2022-09-301189.04%$6.03B$507.4M
2022-06-30-569.44%$5.69B-$999.5M
2022-03-31-3112.90%$6.13B-$196.9M
2021-12-31-1107.26%$5.58B-$504.1M
2021-09-30-262.06%$5.97B-$2.28B
2021-06-30-170.06%$6.07B-$3.57B
2021-03-31-194.83%$6.09B-$3.13B
2020-12-31-144.37%$6.19B-$4.29B
2020-09-30-821.43%$5.57B-$678.4M
2020-06-30-401.52%$5.62B-$1.4B
2020-03-31-218.72%$5.53B-$2.53B
2019-12-31-284.07%$8.32B-$2.93B
2019-09-30-576.67%$7.95B-$1.38B
2019-06-30-386.22%$7.84B-$2.03B
2019-03-31-265.22%$6.26B-$2.36B
2018-12-3138.14%$3.23B$8.47B
2018-09-307.68%$450.1M$5.86B
2018-06-30-4.29%-$143.8M$3.36B
2018-03-3118.00%$1.12B$6.24B
2017-12-31-6.06%-$204.1M$3.37B
2017-09-3034.67%$2.22B$6.42B
2017-06-3042.92%$2.45B$5.7B
2017-03-3138.11%$2.19B$5.74B
2016-12-3146.16%$2.74B$5.93B
2016-09-3036.21%$2.44B$6.75B
2016-06-3042.72%$2.47B$5.77B
2016-03-3137.85%$2.32B$6.13B
2015-12-3142.30%$2.41B$5.69B
2015-09-3034.97%$2.36B$6.74B
2015-06-3034.12%$2.06B$6.04B
2015-03-3134.53%$2.19B$6.35B
2014-12-3122.22%$2.39B$10.76B
2014-09-3020.09%$2.69B$13.39B
2014-06-3024.76%$3.39B$13.7B
2014-03-3127.50%$3.86B$14.05B
2013-12-3135.11%$4.68B$13.34B
2013-09-3039.19%$4.78B$12.21B
2013-06-3046.53%$4.91B$10.55B
2013-03-3145.05%$4.63B$10.27B
2012-12-3140.54%$4.09B$10.09B
2012-09-3028.17%$4.12B$14.62B
2012-06-3031.30%$4.03B$12.87B
2012-03-3132.14%$4.3B$13.39B
2011-12-3135.93%$4.35B$12.1B
2011-09-3034.17%$4.66B$13.63B
2011-06-3036.77%$4.73B$12.85B
2011-03-3138.99%$4.88B$12.51B
2010-12-3146.13%$5.07B$10.99B
2010-09-3042.88%$4.82B$11.23B
2010-06-3049.16%$4.45B$9.06B
2010-03-3145.91%$4.26B$9.29B
2009-12-3151.84%$4.33B$8.35B
2009-09-30-2.18%-$216M$9.91B
2009-06-30-18.96%-$1.62B$8.56B

Annual Return Tang Equity

DateReturn Tang EquityNet income 12 monthTangible equity
2024-12-31334.41%$10.59B$3.17B
2023-12-31889.34%$5.24B$589.2M
2022-12-31456.62%$6.24B$1.37B
2021-12-31-1107.26%$5.58B-$504.1M
2020-12-31-144.37%$6.19B-$4.29B
2019-12-31-284.07%$8.32B-$2.93B
2018-12-3138.14%$3.23B$8.47B
2017-12-31-6.06%-$204.1M$3.37B
2016-12-3146.16%$2.74B$5.93B
2015-12-3142.30%$2.41B$5.69B
2014-12-3122.22%$2.39B$10.76B
2013-12-3135.11%$4.68B$13.34B
2012-12-3140.54%$4.09B$10.09B
2011-12-3135.93%$4.35B$12.1B
2010-12-3146.13%$5.07B$10.99B
2009-12-3151.84%$4.33B$8.35B
2008-12-31-30.75%-$2.07B$6.74B

Similar stocks

Stock NameCountryMarket CapPE Ratio
Akari Therapeutics Plc (AKTX)$1,527.991B-47,921.42
JOHNSON & JOHNSON (JNJ)United States$652.528B29.10
AbbVie Inc. (ABBV)United States$468.180B70.37
Merck & Co., Inc. (MRK)United States$365.215B99.96
ABBOTT LABORATORIES (ABT)United States$176.045B28.47
PFIZER INC (PFE)United States$162.042B31.94
VERTEX PHARMACEUTICALS INC / MA (VRTX)United States$132.481B28.56
BRISTOL MYERS SQUIBB CO (BMY)United States$125.637B12.67
REGENERON PHARMACEUTICALS, INC. (REGN)United States$74.751B21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94